• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Krebs Biochemicals & Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3697.0
  • ISIN : INE268B01013
79.78 0 (-0.27%)
  • As on 28 Jul 2025 (EOD)

  • Today’s Low

    77.10

  • Today’s High

    79.83

  • Open

    79.25

  • Perv Close

    80.00

  • 52W Low

    66.12

  • 52W High

    129.07

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    172.01

  • Div & Yield %

    0.00

  • Book Value(₹)

    -67.83

  • Debt-Equity Ratio

    -0.27

  • AGM Date

    25-Jul-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    172.01

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    21.56

  • BV (₹)

    -67.80

  • Sales( ₹ in Cr.)

    43.31

  • NP (in Cr.)

    -26.94

  • NP Var(%)

    -37.0

  • Div%

    0.0

  • CPS (₹)

    -9.40

  • EPS (₹)

    -12.50

  • Traded Value (₹ in Lakhs)

    169.16

  • 52 Week High

    129.07

  • 52 Week Low

    66.12

  • Price BSE

    78.0

  • Price NSE

    80.00

  • Market Capital( in Cr.)

    169.16

  • P/C Ratio

    -8.30

  • P/E Ratio

    -6.20

  • Price Vs.BV

    -12.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 50.42 52.13 59.70 53.70 33.41 47.76
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 50.42 52.13 59.70 53.70 33.41 47.76
Other Income 0.45 0.62 1.16 0.62 0.37 0.44
Stock Adjustments -1.07 -5.87 5.54 -0.32 3.32 -2.11
Total Income 49.80 46.88 66.40 54.00 37.10 46.09
EXPENDITURE :            
Raw Materials 5.52 19.81 46.18 25.62 19.18 20.99
Power and Fuel Cost 22.01 14.80 22.23 15.91 10.28 11.70
Employee Cost 16.17 15.54 14.96 15.30 14.56 14.41
Other Manufacturing Expenses 9.75 7.17 9.64 10.48 6.95 4.27
Selling and Administration Expenses 4.50 4.57 6.11 3.39 4.01 3.83
Miscellaneous Expenses 0.11 0.17 0.11 0.24 0.31 0.20
Employee Benefit Expenses 16.17 15.54 14.96 15.30 14.56 14.41
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 58.08 62.05 99.24 70.95 55.29 55.41
Operating Profit -8.27 -15.16 -32.84 -16.95 -18.19 -9.32
Interest 4.69 2.97 5.39 6.28 6.00 6.29
Gross Profit -12.96 -18.13 -38.23 -23.23 -24.19 -15.61
Depreciation 6.77 6.56 6.30 5.12 4.68 4.40
Profit Before Tax -19.73 -24.69 -44.53 -28.35 -28.87 -20.01
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -19.73 -24.69 -44.53 -28.36 -28.87 -20.01
Extraordinary Items 0.00 0.00 0.00 0.00 0.01 0.11
Adjusted Net Profit -19.73 -24.69 -44.53 -28.36 -28.88 -20.12
Adjustment below Net Profit -0.03 0.32 -0.35 0.17 6.38 -1.32
P & L Balance brought forward -250.49 -226.12 -181.24 -153.06 -111.86 -90.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -270.24 -250.49 -226.12 -181.24 -134.35 -111.86
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -9.15 -11.45 -20.65 -14.45 -16.04 0.00
Earnings Per Share(Adj)-Unit Curr -9.15 -11.45 -20.65 -14.45 -16.04 0.00
Book Value -55.29 -46.13 -34.83 -23.91 -13.89 -8.59
Book Value(Adj)-Unit Curr -55.29 -46.13 -34.83 -23.91 -13.89 -8.59

Shareholding Pattern

  • Promoter Group

    72.74%

  • Public Share Holding

    27.26%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,705,195 49.65 10,705,195 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,978,939 23.09 4,958,539 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 15,684,134 72.74 15,663,734 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 105,000 0.49 105,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 1,822 0.01 522 4
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 106,822 0.50 105,522 5
2] Non Institution
Bodies Corporate 1,082,727 5.02 1,079,126 79
Clearing Members 0 0.00 0 0
Directors of their Relatives 105 0.00 105 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 290,899 1.35 290,899 94
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 142,572 0.66 142,572 201
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,737,004 8.06 1,527,004 21
Individuals holding nominal share capital up to Rs. 1 lakh 2,516,321 11.67 2,398,791 8,708
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2 0.00 2 2
Sub Total 5,769,630 26.76 5,438,499 9,107
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 21,560,586 100.00 21,207,755 9,118

Company Background

Krebs Biochemicals & Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Krebs Biochemicals & Industries Ltd
  • BSE Code : 3697.0
  • ISIN : INE268B01013

  • Incorporation Year

    1991

  • Registered Office

    Kothapalli(V) Kasimkota(M)
    Anakapalli, Vishakapatnam,
    Andhra Pradesh-531031

  • Telephone

    91-040-6680 8040

  • FAX

  • Chairman

    R T Ravi

  • Managing Director

    Jitendra Shah

  • Company Secretary

    Keyur Doshi

  • Auditor

    Bhavani & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Krebs Biochemicals & Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Krebs Biochem 78.46 50.87 50.42 -6.28 0.00
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10